{"transactions":[{"id":1459911,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-07-03T20:13:01.000Z","date":"2024-07-02","kind":"sale","planned":true,"acquired":false,"shares":33,"price":13.9,"value":458.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2023."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-019169","document":"form4-07032024_080758.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924019169/form4-07032024_080758.xml","form_type":"4"}},{"id":1459910,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-07-03T20:13:01.000Z","date":"2024-07-02","kind":"sale","planned":true,"acquired":false,"shares":2467,"price":13.101,"value":32320.167,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.83 to $13.74 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The shares sold in the reported transactions include an aggregate 2,500 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan in one or more transactions exempt pursuant to Rules 16b-3(c) and 16b-3(d)."}],"balance_after":33,"source":{"system":"sec-edgar","filing":"0001415889-24-019169","document":"form4-07032024_080758.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924019169/form4-07032024_080758.xml","form_type":"4"}},{"id":1486732,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Restricted Stock Units","published_at":"2024-06-07T20:41:20.000Z","date":"2024-03-27","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The award vests as to 1/4 of the total award annually beginning on March 15, 2025, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":40000,"derivative":{"expiration_date":"2028-03-15","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-24-016008","document":"form4-06072024_080616.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924016008/form4-06072024_080616.xml","form_type":"4"}},{"id":1486731,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-06-07T20:41:20.000Z","date":"2024-03-27","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested or vests as to 1/48 of the total award on April 15, 2024, with 1/48 vesting on each monthly anniversary thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":60000,"derivative":{"exercise_price":14.17,"expiration_date":"2034-03-26","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001415889-24-016008","document":"form4-06072024_080616.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924016008/form4-06072024_080616.xml","form_type":"4"}},{"id":1505437,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-22T20:20:11.000Z","date":"2024-05-20","kind":"exercise","planned":true,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested."}],"balance_after":46000,"derivative":{"exercise_price":0.4,"expiration_date":"2026-02-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-24-014093","document":"form4-05222024_080503.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924014093/form4-05222024_080503.xml","form_type":"4"}},{"id":1505436,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2024-05-22T20:20:11.000Z","date":"2024-05-20","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":15.39,"value":769500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.91 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-014093","document":"form4-05222024_080503.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924014093/form4-05222024_080503.xml","form_type":"4"}},{"id":1505435,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2024-05-22T20:20:11.000Z","date":"2024-05-20","kind":"exercise","planned":true,"acquired":true,"shares":50000,"price":0.4,"value":20000.0,"ownership":{"direct":true},"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001415889-24-014093","document":"form4-05222024_080503.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924014093/form4-05222024_080503.xml","form_type":"4"}},{"id":1549544,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-03T20:19:26.000Z","date":"2024-04-01","kind":"exercise","planned":true,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested."}],"balance_after":96000,"derivative":{"exercise_price":0.4,"expiration_date":"2026-02-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-24-009993","document":"form4-04032024_080414.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924009993/form4-04032024_080414.xml","form_type":"4"}},{"id":1549543,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2024-04-03T20:19:26.000Z","date":"2024-04-01","kind":"sale","planned":true,"acquired":false,"shares":400,"price":13.61,"value":5444.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2023."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-009993","document":"form4-04032024_080414.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924009993/form4-04032024_080414.xml","form_type":"4"}},{"id":1549542,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2024-04-03T20:19:26.000Z","date":"2024-04-01","kind":"sale","planned":true,"acquired":false,"shares":60929,"price":13.2247,"value":805767.7463,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.60 to $13.59 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":400,"source":{"system":"sec-edgar","filing":"0001415889-24-009993","document":"form4-04032024_080414.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924009993/form4-04032024_080414.xml","form_type":"4"}},{"id":1549541,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2024-04-03T20:19:26.000Z","date":"2024-04-01","kind":"exercise","planned":true,"acquired":true,"shares":50000,"price":0.4,"value":20000.0,"ownership":{"direct":true},"balance_after":61329,"source":{"system":"sec-edgar","filing":"0001415889-24-009993","document":"form4-04032024_080414.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924009993/form4-04032024_080414.xml","form_type":"4"}},{"id":1568617,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Restricted Stock Units","published_at":"2024-03-20T00:31:55.000Z","date":"2024-03-15","kind":"exercise","planned":false,"acquired":false,"shares":13100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The award vested or vests as to 1/4th of the total shares annually beginning March 15, 2024, subject to the reporting person's continued service to the Issuer through each vesting date."}],"balance_after":39300,"derivative":{"expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":13100},"source":{"system":"sec-edgar","filing":"0001415889-24-008686","document":"form4-03202024_120349.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924008686/form4-03202024_120349.xml","form_type":"4"}},{"id":1568616,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2024-03-20T00:31:55.000Z","date":"2024-03-19","kind":"sale","planned":false,"acquired":false,"shares":4116,"price":6.0986,"value":25101.8376,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.94 to $6.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":11329,"source":{"system":"sec-edgar","filing":"0001415889-24-008686","document":"form4-03202024_120349.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924008686/form4-03202024_120349.xml","form_type":"4"}},{"id":1568615,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2024-03-20T00:31:55.000Z","date":"2024-03-15","kind":"exercise","planned":false,"acquired":true,"shares":13100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported total includes an aggregate 2,345 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan in one or more transactions exempt pursuant to Rules 16b-3(c) and 16b-3(d)."}],"balance_after":15445,"source":{"system":"sec-edgar","filing":"0001415889-24-008686","document":"form4-03202024_120349.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924008686/form4-03202024_120349.xml","form_type":"4"}},{"id":1721655,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2023-12-05T21:17:17.000Z","date":"2023-12-01","kind":"grant","planned":false,"acquired":true,"shares":8463,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"7,053 restricted stock units will vest on December 1, 2024 and 1,410 will vest on December 1, 2025, subject to the reporting person's continued service to the Issuer on each such date."}],"balance_after":8463,"derivative":{"expiration_date":"2025-12-01","underlying":"Common Stock","underlying_shares":8463},"source":{"system":"sec-edgar","filing":"0001209191-23-057403","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919123057403/doc4.xml","form_type":"4"}},{"id":1721654,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-12-05T21:17:17.000Z","date":"2023-12-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":65600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 1, 2023, the Issuer cancelled, pursuant to the Issuer's option exchange program, options to purchase 65,600 shares of Common Stock of the Issuer and in exchange issued to the reporting person 8,463 restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The canceled option vested as to 1/48th of the total award on April 2, 2021 and provided for 1/48th of the total award to vest monthly thereafter, subject to the reporting person's continued service to the Issuer through each vesting date."}],"balance_after":0,"derivative":{"exercise_price":60,"expiration_date":"2031-03-01","underlying":"Common Stock","underlying_shares":65600},"source":{"system":"sec-edgar","filing":"0001209191-23-057403","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919123057403/doc4.xml","form_type":"4"}},{"id":1946959,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2023-03-17T20:33:53.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":52400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/4th of the total shares annually beginning March 15, 2024, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":52400,"derivative":{"expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":52400},"source":{"system":"sec-edgar","filing":"0001209191-23-019656","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919123019656/doc4.xml","form_type":"4"}},{"id":1946958,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-03-17T20:33:53.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":78600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/48th of the total shares on April 15, 2023 and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":78600,"derivative":{"exercise_price":9.15,"expiration_date":"2033-03-14","underlying":"Common Stock","underlying_shares":78600},"source":{"system":"sec-edgar","filing":"0001209191-23-019656","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919123019656/doc4.xml","form_type":"4"}},{"id":2091086,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-12-09T22:10:57.000Z","date":"2022-12-07","kind":"grant","acquired":true,"shares":62000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/48th of the total shares on January 7, 2023 and then 1/48th of the total shares vest monthly thereafter, subject to reporting\nperson's continued service to the issuer through each vesting date."}],"balance_after":62000,"derivative":{"exercise_price":7.07,"expiration_date":"2032-12-06","underlying":"Common Stock","underlying_shares":62000},"source":{"system":"sec-edgar","filing":"0001209191-22-060546","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919122060546/doc4.xml","form_type":"4"}},{"id":2327431,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-03-17T21:13:55.000Z","date":"2022-03-15","kind":"grant","acquired":true,"shares":107400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/48th of the total shares on April 15, 2022 and then 1/48th of the total shares vest monthly thereafter, subject to reporting\nperson's continued service to the issuer through each vesting date."}],"balance_after":107400,"derivative":{"exercise_price":20.34,"expiration_date":"2032-03-14","underlying":"Common Stock","underlying_shares":107400},"source":{"system":"sec-edgar","filing":"0001209191-22-019684","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919122019684/doc4.xml","form_type":"4"}},{"id":2443920,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-01-05T22:35:11.000Z","date":"2022-01-03","kind":"exercise","acquired":false,"shares":3800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested as to 1/48th of the total shares on November 22, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":86822,"derivative":{"exercise_price":2.19,"expiration_date":"2028-12-12","underlying":"Common Stock","underlying_shares":3800},"source":{"system":"sec-edgar","filing":"0001209191-22-001849","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919122001849/doc4.xml","form_type":"4"}},{"id":2443919,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2022-01-05T22:35:11.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":200,"price":24.07,"value":4814.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-001849","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919122001849/doc4.xml","form_type":"4"}},{"id":2443918,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2022-01-05T22:35:11.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":2103,"price":23.4042,"value":49219.0326,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $23.03 to $23.83 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":200,"source":{"system":"sec-edgar","filing":"0001209191-22-001849","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919122001849/doc4.xml","form_type":"4"}},{"id":2443917,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2022-01-05T22:35:11.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":1497,"price":22.467,"value":33633.099,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $21.98 to $22.95 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":2303,"source":{"system":"sec-edgar","filing":"0001209191-22-001849","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919122001849/doc4.xml","form_type":"4"}},{"id":2443916,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2022-01-05T22:35:11.000Z","date":"2022-01-03","kind":"exercise","acquired":true,"shares":3800,"price":2.19,"value":8322.0,"ownership":{"direct":true},"balance_after":3800,"source":{"system":"sec-edgar","filing":"0001209191-22-001849","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919122001849/doc4.xml","form_type":"4"}},{"id":2485877,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-12-03T23:15:23.000Z","date":"2021-12-01","kind":"exercise","acquired":false,"shares":5700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested as to 1/48th of the total shares on November 22, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":90622,"derivative":{"exercise_price":2.19,"expiration_date":"2028-12-12","underlying":"Common Stock","underlying_shares":5700},"source":{"system":"sec-edgar","filing":"0001209191-21-067950","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121067950/doc4.xml","form_type":"4"}},{"id":2485876,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2021-12-03T23:15:23.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":2500,"price":25.0624,"value":62656.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $24.56 to $25.13 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-067950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121067950/doc4.xml","form_type":"4"}},{"id":2485875,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2021-12-03T23:15:23.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":3200,"price":23.9605,"value":76673.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $23.45 to $24.42 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001209191-21-067950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121067950/doc4.xml","form_type":"4"}},{"id":2485874,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2021-12-03T23:15:23.000Z","date":"2021-12-01","kind":"exercise","acquired":true,"shares":5700,"price":2.19,"value":12483.0,"ownership":{"direct":true},"balance_after":5700,"source":{"system":"sec-edgar","filing":"0001209191-21-067950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121067950/doc4.xml","form_type":"4"}},{"id":2526307,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-11-03T22:05:35.000Z","date":"2021-11-03","kind":"exercise","acquired":false,"shares":1900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested as to 1/48th of the total shares on November 22, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":96322,"derivative":{"exercise_price":2.19,"expiration_date":"2028-12-12","underlying":"Common Stock","underlying_shares":1900},"source":{"system":"sec-edgar","filing":"0001209191-21-062772","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121062772/doc4.xml","form_type":"4"}},{"id":2526306,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-11-03T22:05:35.000Z","date":"2021-11-01","kind":"exercise","acquired":false,"shares":3800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested as to 1/48th of the total shares on November 22, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":98222,"derivative":{"exercise_price":2.19,"expiration_date":"2028-12-12","underlying":"Common Stock","underlying_shares":3800},"source":{"system":"sec-edgar","filing":"0001209191-21-062772","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121062772/doc4.xml","form_type":"4"}},{"id":2526305,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2021-11-03T22:05:35.000Z","date":"2021-11-03","kind":"sale","acquired":false,"shares":1900,"price":25,"value":47500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-062772","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121062772/doc4.xml","form_type":"4"}},{"id":2526304,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2021-11-03T22:05:35.000Z","date":"2021-11-03","kind":"exercise","acquired":true,"shares":1900,"price":2.19,"value":4161.0,"ownership":{"direct":true},"balance_after":1900,"source":{"system":"sec-edgar","filing":"0001209191-21-062772","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121062772/doc4.xml","form_type":"4"}},{"id":2526303,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2021-11-03T22:05:35.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":1610,"price":23.7237,"value":38195.157,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $23.68 to $23.76 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-062772","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121062772/doc4.xml","form_type":"4"}},{"id":2526302,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2021-11-03T22:05:35.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":2190,"price":23.407,"value":51261.33,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $22.67 to $23.66 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1610,"source":{"system":"sec-edgar","filing":"0001209191-21-062772","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121062772/doc4.xml","form_type":"4"}},{"id":2526301,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2021-11-03T22:05:35.000Z","date":"2021-11-01","kind":"exercise","acquired":true,"shares":3800,"price":2.19,"value":8322.0,"ownership":{"direct":true},"balance_after":3800,"source":{"system":"sec-edgar","filing":"0001209191-21-062772","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121062772/doc4.xml","form_type":"4"}},{"id":2552027,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-10-04T21:51:28.000Z","date":"2021-10-01","kind":"exercise","acquired":false,"shares":5700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested as to 1/48th of the total shares on November 22, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":102022,"derivative":{"exercise_price":2.19,"expiration_date":"2028-12-12","underlying":"Common Stock","underlying_shares":5700},"source":{"system":"sec-edgar","filing":"0001209191-21-059111","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121059111/doc4.xml","form_type":"4"}},{"id":2552026,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2021-10-04T21:51:28.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":5700,"price":24.8256,"value":141505.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $24.42 to $25.38 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-059111","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121059111/doc4.xml","form_type":"4"}},{"id":2552025,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2021-10-04T21:51:28.000Z","date":"2021-10-01","kind":"exercise","acquired":true,"shares":5700,"price":2.19,"value":12483.0,"ownership":{"direct":true},"balance_after":5700,"source":{"system":"sec-edgar","filing":"0001209191-21-059111","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121059111/doc4.xml","form_type":"4"}},{"id":2581640,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-09-02T22:30:25.000Z","date":"2021-09-01","kind":"exercise","acquired":false,"shares":5700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested as to 1/48th of the total shares on November 22, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":107722,"derivative":{"exercise_price":2.19,"expiration_date":"2028-12-12","underlying":"Common Stock","underlying_shares":5700},"source":{"system":"sec-edgar","filing":"0001209191-21-054552","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121054552/doc4.xml","form_type":"4"}},{"id":2581639,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2021-09-02T22:30:25.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":5700,"price":26.004,"value":148222.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $25.68 to $26.49 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-054552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121054552/doc4.xml","form_type":"4"}},{"id":2581638,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2021-09-02T22:30:25.000Z","date":"2021-09-01","kind":"exercise","acquired":true,"shares":5700,"price":2.19,"value":12483.0,"ownership":{"direct":true},"balance_after":5700,"source":{"system":"sec-edgar","filing":"0001209191-21-054552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121054552/doc4.xml","form_type":"4"}},{"id":2614840,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-08-04T23:41:08.000Z","date":"2021-08-02","kind":"exercise","acquired":false,"shares":5700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested as to 1/48th of the total shares on November 22, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":113422,"derivative":{"exercise_price":2.19,"expiration_date":"2028-12-12","underlying":"Common Stock","underlying_shares":5700},"source":{"system":"sec-edgar","filing":"0001209191-21-049793","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121049793/doc4.xml","form_type":"4"}},{"id":2614839,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2021-08-04T23:41:08.000Z","date":"2021-08-02","kind":"sale","acquired":false,"shares":5700,"price":28.8692,"value":164554.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $28.68 to $29.32 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-049793","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121049793/doc4.xml","form_type":"4"}},{"id":2614838,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2021-08-04T23:41:08.000Z","date":"2021-08-02","kind":"exercise","acquired":true,"shares":5700,"price":2.19,"value":12483.0,"ownership":{"direct":true},"balance_after":5700,"source":{"system":"sec-edgar","filing":"0001209191-21-049793","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121049793/doc4.xml","form_type":"4"}},{"id":2644707,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-07-02T21:41:05.000Z","date":"2021-07-01","kind":"exercise","acquired":false,"shares":5700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested as to 1/48th of the total shares on November 22, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":119122,"derivative":{"exercise_price":2.19,"expiration_date":"2028-12-12","underlying":"Common Stock","underlying_shares":5700},"source":{"system":"sec-edgar","filing":"0001209191-21-045097","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121045097/doc4.xml","form_type":"4"}},{"id":2644706,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2021-07-02T21:41:05.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":5700,"price":33.331,"value":189986.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $33.03 to $33.80 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-045097","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121045097/doc4.xml","form_type":"4"}},{"id":2644705,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2021-07-02T21:41:05.000Z","date":"2021-07-01","kind":"exercise","acquired":true,"shares":5700,"price":2.19,"value":12483.0,"ownership":{"direct":true},"balance_after":5700,"source":{"system":"sec-edgar","filing":"0001209191-21-045097","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121045097/doc4.xml","form_type":"4"}},{"id":2683258,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-06-03T21:48:13.000Z","date":"2021-06-01","kind":"exercise","acquired":false,"shares":575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested as to 1/48th of the total shares on November 22, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":124822,"derivative":{"exercise_price":2.19,"expiration_date":"2028-12-12","underlying":"Common Stock","underlying_shares":575},"source":{"system":"sec-edgar","filing":"0001209191-21-037839","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121037839/doc4.xml","form_type":"4"}},{"id":2683257,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2021-06-03T21:48:13.000Z","date":"2021-06-01","kind":"sale","acquired":false,"shares":575,"price":39.4252,"value":22669.49,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $39.17 to $39.70 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-037839","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121037839/doc4.xml","form_type":"4"}},{"id":2683256,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2021-06-03T21:48:13.000Z","date":"2021-06-01","kind":"exercise","acquired":true,"shares":575,"price":2.19,"value":1259.25,"ownership":{"direct":true},"balance_after":575,"source":{"system":"sec-edgar","filing":"0001209191-21-037839","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121037839/doc4.xml","form_type":"4"}},{"id":2808800,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-03-04T22:01:44.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":65600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/48th of the total shares on April 2, 2021 and then 1/48th of the total shares vest monthly thereafter, subject to reporting person's continued service to the issuer through each vesting date."}],"balance_after":65600,"derivative":{"exercise_price":60,"expiration_date":"2031-03-01","underlying":"Common Stock","underlying_shares":65600},"source":{"system":"sec-edgar","filing":"0001209191-21-017874","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121017874/doc4.xml","form_type":"4"}},{"id":2915738,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-01-06T22:26:26.000Z","date":"2021-01-04","kind":"exercise","acquired":false,"shares":5700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vested as to 1/48th of the total shares on November 22, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":125397,"derivative":{"exercise_price":2.19,"expiration_date":"2018-12-12","underlying":"Common Stock","underlying_shares":5700},"source":{"system":"sec-edgar","filing":"0001209191-21-002246","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121002246/doc4.xml","form_type":"4"}},{"id":2915737,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2021-01-06T22:26:26.000Z","date":"2021-01-06","kind":"sale","acquired":false,"shares":32,"price":57.1401,"value":1828.4832,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-002246","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121002246/doc4.xml","form_type":"4"}},{"id":2915736,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2021-01-06T22:26:26.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":200,"price":60.5075,"value":12101.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $60.50 to $60.515 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":32,"source":{"system":"sec-edgar","filing":"0001209191-21-002246","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121002246/doc4.xml","form_type":"4"}},{"id":2915735,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2021-01-06T22:26:26.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":1800,"price":59.8469,"value":107724.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $59.395 to $60.33 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":232,"source":{"system":"sec-edgar","filing":"0001209191-21-002246","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121002246/doc4.xml","form_type":"4"}},{"id":2915734,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2021-01-06T22:26:26.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":2200,"price":59.0168,"value":129836.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $58.395 to $59.355 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":2032,"source":{"system":"sec-edgar","filing":"0001209191-21-002246","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121002246/doc4.xml","form_type":"4"}},{"id":2915733,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2021-01-06T22:26:26.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":1500,"price":57.6627,"value":86494.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $57.33 to $58.13 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":4232,"source":{"system":"sec-edgar","filing":"0001209191-21-002246","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121002246/doc4.xml","form_type":"4"}},{"id":2915732,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2021-01-06T22:26:26.000Z","date":"2021-01-04","kind":"exercise","acquired":true,"shares":5700,"price":2.19,"value":12483.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 32 shares of  Common Stock acquired under the issuer's employee stock purchase plan on December 31, 2020."}],"balance_after":5732,"source":{"system":"sec-edgar","filing":"0001209191-21-002246","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121002246/doc4.xml","form_type":"4"}},{"id":2937879,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-12-19T02:08:39.000Z","date":"2020-12-18","kind":"exercise","acquired":false,"shares":8015,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested as to  1/48th of the total shares on February 28, 2018, and then 1/48th of the total shares vest at the end of each month thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":172371,"derivative":{"exercise_price":0.6,"expiration_date":"2028-04-02","underlying":"Common Stock","underlying_shares":8015},"source":{"system":"sec-edgar","filing":"0001209191-20-064582","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120064582/doc4.xml","form_type":"4"}},{"id":2937878,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-12-19T02:08:39.000Z","date":"2020-12-17","kind":"exercise","acquired":false,"shares":41985,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested as to  1/48th of the total shares on February 28, 2018, and then 1/48th of the total shares vest at the end of each month thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":180386,"derivative":{"exercise_price":0.6,"expiration_date":"2028-04-02","underlying":"Common Stock","underlying_shares":41985},"source":{"system":"sec-edgar","filing":"0001209191-20-064582","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120064582/doc4.xml","form_type":"4"}},{"id":2937877,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2020-12-19T02:08:39.000Z","date":"2020-12-18","kind":"sale","acquired":false,"shares":8015,"price":60,"value":480900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-064582","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120064582/doc4.xml","form_type":"4"}},{"id":2937876,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2020-12-19T02:08:39.000Z","date":"2020-12-18","kind":"exercise","acquired":true,"shares":8015,"price":0.6,"value":4809.0,"ownership":{"direct":true},"balance_after":8015,"source":{"system":"sec-edgar","filing":"0001209191-20-064582","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120064582/doc4.xml","form_type":"4"}},{"id":2937875,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2020-12-19T02:08:39.000Z","date":"2020-12-17","kind":"sale","acquired":false,"shares":41985,"price":60,"value":2519100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-064582","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120064582/doc4.xml","form_type":"4"}},{"id":2937874,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2020-12-19T02:08:39.000Z","date":"2020-12-17","kind":"exercise","acquired":true,"shares":41985,"price":0.6,"value":25191.0,"ownership":{"direct":true},"balance_after":41985,"source":{"system":"sec-edgar","filing":"0001209191-20-064582","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120064582/doc4.xml","form_type":"4"}},{"id":2958521,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-12-03T23:00:05.000Z","date":"2020-12-01","kind":"exercise","acquired":false,"shares":5700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vested as to 1/48th of the total shares on November 22, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":131097,"derivative":{"exercise_price":2.19,"expiration_date":"2018-12-12","underlying":"Common Stock","underlying_shares":5700},"source":{"system":"sec-edgar","filing":"0001209191-20-061591","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120061591/doc4.xml","form_type":"4"}},{"id":2958520,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2020-12-03T23:00:05.000Z","date":"2020-12-01","kind":"sale","acquired":false,"shares":400,"price":52.72,"value":21088.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $52.63 to $52.99 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-061591","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120061591/doc4.xml","form_type":"4"}},{"id":2958519,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2020-12-03T23:00:05.000Z","date":"2020-12-01","kind":"sale","acquired":false,"shares":100,"price":51.45,"value":5145.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":400,"source":{"system":"sec-edgar","filing":"0001209191-20-061591","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120061591/doc4.xml","form_type":"4"}},{"id":2958518,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2020-12-03T23:00:05.000Z","date":"2020-12-01","kind":"sale","acquired":false,"shares":2481,"price":50.0214,"value":124103.0934,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $49.78 to $50.41 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":500,"source":{"system":"sec-edgar","filing":"0001209191-20-061591","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120061591/doc4.xml","form_type":"4"}},{"id":2958517,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2020-12-03T23:00:05.000Z","date":"2020-12-01","kind":"sale","acquired":false,"shares":2719,"price":49.1885,"value":133743.5315,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $48.74 to $49.69 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":2981,"source":{"system":"sec-edgar","filing":"0001209191-20-061591","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120061591/doc4.xml","form_type":"4"}},{"id":2958516,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2020-12-03T23:00:05.000Z","date":"2020-12-01","kind":"exercise","acquired":true,"shares":5700,"price":2.19,"value":12483.0,"ownership":{"direct":true},"balance_after":5700,"source":{"system":"sec-edgar","filing":"0001209191-20-061591","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120061591/doc4.xml","form_type":"4"}},{"id":2986528,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-11-10T22:42:25.000Z","date":"2020-11-10","kind":"exercise","acquired":false,"shares":13414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested as to 1/48th of the total shares on November 22, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":136797,"derivative":{"exercise_price":2.19,"expiration_date":"2028-12-12","underlying":"Common Stock","underlying_shares":13414},"source":{"system":"sec-edgar","filing":"0001209191-20-057717","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120057717/doc4.xml","form_type":"4"}},{"id":2986527,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-11-10T22:42:25.000Z","date":"2020-11-10","kind":"exercise","acquired":false,"shares":36586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested as to  1/48th of the total shares on February 28, 2018, and then 1/48th of the total shares vest at the end of each month thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":222371,"derivative":{"exercise_price":0.6,"expiration_date":"2028-04-02","underlying":"Common Stock","underlying_shares":36586},"source":{"system":"sec-edgar","filing":"0001209191-20-057717","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120057717/doc4.xml","form_type":"4"}},{"id":2986526,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2020-11-10T22:42:25.000Z","date":"2020-11-10","kind":"sale","acquired":false,"shares":50000,"price":45,"value":2250000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-057717","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120057717/doc4.xml","form_type":"4"}},{"id":2986525,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2020-11-10T22:42:25.000Z","date":"2020-11-10","kind":"exercise","acquired":true,"shares":13414,"price":2.19,"value":29376.66,"ownership":{"direct":true},"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001209191-20-057717","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120057717/doc4.xml","form_type":"4"}},{"id":2986524,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2020-11-10T22:42:25.000Z","date":"2020-11-10","kind":"exercise","acquired":true,"shares":36586,"price":0.6,"value":21951.6,"ownership":{"direct":true},"balance_after":36586,"source":{"system":"sec-edgar","filing":"0001209191-20-057717","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120057717/doc4.xml","form_type":"4"}},{"id":2992823,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-11-04T22:30:24.000Z","date":"2020-11-02","kind":"exercise","acquired":false,"shares":5700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested as to 1/48th of the total shares on November 22, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":150211,"derivative":{"exercise_price":2.19,"expiration_date":"2018-12-12","underlying":"Common Stock","underlying_shares":5700},"source":{"system":"sec-edgar","filing":"0001209191-20-056950","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120056950/doc4.xml","form_type":"4"}},{"id":2992822,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2020-11-04T22:30:24.000Z","date":"2020-11-02","kind":"sale","acquired":false,"shares":2536,"price":37.983,"value":96324.888,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $37.41 to $38.32 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-056950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120056950/doc4.xml","form_type":"4"}},{"id":2992821,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2020-11-04T22:30:24.000Z","date":"2020-11-02","kind":"sale","acquired":false,"shares":3164,"price":36.5945,"value":115784.998,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $36.36 to $37.355 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":2536,"source":{"system":"sec-edgar","filing":"0001209191-20-056950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120056950/doc4.xml","form_type":"4"}},{"id":2992820,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2020-11-04T22:30:24.000Z","date":"2020-11-02","kind":"exercise","acquired":true,"shares":5700,"price":2.19,"value":12483.0,"ownership":{"direct":true},"balance_after":5700,"source":{"system":"sec-edgar","filing":"0001209191-20-056950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120056950/doc4.xml","form_type":"4"}},{"id":3013271,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-10-05T21:12:05.000Z","date":"2020-10-01","kind":"exercise","acquired":false,"shares":5700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested as to 1/48th of the total shares on November 22, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":155911,"derivative":{"exercise_price":2.19,"expiration_date":"2018-12-12","underlying":"Common Stock","underlying_shares":5700},"source":{"system":"sec-edgar","filing":"0001209191-20-053732","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120053732/doc4.xml","form_type":"4"}},{"id":3013270,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2020-10-05T21:12:05.000Z","date":"2020-10-01","kind":"sale","acquired":false,"shares":2300,"price":34.862,"value":80182.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $34.635 to $35.00 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-053732","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120053732/doc4.xml","form_type":"4"}},{"id":3013269,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2020-10-05T21:12:05.000Z","date":"2020-10-01","kind":"sale","acquired":false,"shares":3400,"price":34.3288,"value":116717.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $33.65 to $34.61 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":2300,"source":{"system":"sec-edgar","filing":"0001209191-20-053732","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120053732/doc4.xml","form_type":"4"}},{"id":3013268,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2020-10-05T21:12:05.000Z","date":"2020-10-01","kind":"exercise","acquired":true,"shares":5700,"price":2.19,"value":12483.0,"ownership":{"direct":true},"balance_after":5700,"source":{"system":"sec-edgar","filing":"0001209191-20-053732","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120053732/doc4.xml","form_type":"4"}},{"id":3034388,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-09-10T22:21:34.000Z","date":"2020-09-09","kind":"exercise","acquired":false,"shares":17201,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested as to 1/48th of the total shares on November 22, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":161611,"derivative":{"exercise_price":2.19,"expiration_date":"2018-12-12","underlying":"Common Stock","underlying_shares":17201},"source":{"system":"sec-edgar","filing":"0001209191-20-050031","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120050031/doc4.xml","form_type":"4"}},{"id":3034387,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-09-10T22:21:34.000Z","date":"2020-09-08","kind":"exercise","acquired":false,"shares":30718,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested as to 1/48th of the total shares on November 22, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":178812,"derivative":{"exercise_price":2.19,"expiration_date":"2018-12-12","underlying":"Common Stock","underlying_shares":30718},"source":{"system":"sec-edgar","filing":"0001209191-20-050031","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120050031/doc4.xml","form_type":"4"}},{"id":3034386,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2020-09-10T22:21:34.000Z","date":"2020-09-09","kind":"sale","acquired":false,"shares":17201,"price":30,"value":516030.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-050031","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120050031/doc4.xml","form_type":"4"}},{"id":3034385,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2020-09-10T22:21:34.000Z","date":"2020-09-09","kind":"exercise","acquired":true,"shares":17201,"price":2.19,"value":37670.19,"ownership":{"direct":true},"balance_after":17201,"source":{"system":"sec-edgar","filing":"0001209191-20-050031","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120050031/doc4.xml","form_type":"4"}},{"id":3034384,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2020-09-10T22:21:34.000Z","date":"2020-09-08","kind":"sale","acquired":false,"shares":30718,"price":30,"value":921540.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-050031","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120050031/doc4.xml","form_type":"4"}},{"id":3034383,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2020-09-10T22:21:34.000Z","date":"2020-09-08","kind":"exercise","acquired":true,"shares":30718,"price":2.19,"value":67272.42,"ownership":{"direct":true},"balance_after":30718,"source":{"system":"sec-edgar","filing":"0001209191-20-050031","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120050031/doc4.xml","form_type":"4"}},{"id":3039272,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-09-03T22:35:15.000Z","date":"2020-09-01","kind":"exercise","acquired":false,"shares":5700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests 1/48th of the shares monthly,commencing one month from the date of grant,  subject to reporting person's continued service through each vesting date."}],"balance_after":209530,"derivative":{"exercise_price":2.19,"expiration_date":"2018-12-12","underlying":"Common Stock","underlying_shares":5700},"source":{"system":"sec-edgar","filing":"0001209191-20-049551","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120049551/doc4.xml","form_type":"4"}},{"id":3039271,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2020-09-03T22:35:15.000Z","date":"2020-09-01","kind":"sale","acquired":false,"shares":700,"price":28.7109,"value":20097.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $28.53 to $29.06 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-049551","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120049551/doc4.xml","form_type":"4"}},{"id":3039270,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2020-09-03T22:35:15.000Z","date":"2020-09-01","kind":"sale","acquired":false,"shares":5000,"price":27.603,"value":138015.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $27.50 to $27.84 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":700,"source":{"system":"sec-edgar","filing":"0001209191-20-049551","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120049551/doc4.xml","form_type":"4"}},{"id":3039269,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2020-09-03T22:35:15.000Z","date":"2020-09-01","kind":"exercise","acquired":true,"shares":5700,"price":2.19,"value":12483.0,"ownership":{"direct":true},"balance_after":5700,"source":{"system":"sec-edgar","filing":"0001209191-20-049551","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120049551/doc4.xml","form_type":"4"}},{"id":3043754,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-08-31T22:04:16.000Z","date":"2020-08-28","kind":"exercise","acquired":false,"shares":2081,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests 1/48th of the shares monthly,commencing one month from the date of grant,  subject to reporting person's continued service through each vesting date."}],"balance_after":215230,"derivative":{"exercise_price":2.19,"expiration_date":"2018-12-12","underlying":"Common Stock","underlying_shares":2081},"source":{"system":"sec-edgar","filing":"0001209191-20-048841","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120048841/doc4.xml","form_type":"4"}},{"id":3043753,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2020-08-31T22:04:16.000Z","date":"2020-08-28","kind":"sale","acquired":false,"shares":2081,"price":30,"value":62430.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-048841","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120048841/doc4.xml","form_type":"4"}},{"id":3043752,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2020-08-31T22:04:16.000Z","date":"2020-08-28","kind":"exercise","acquired":true,"shares":2081,"price":2.19,"value":4557.39,"ownership":{"direct":true},"balance_after":2081,"source":{"system":"sec-edgar","filing":"0001209191-20-048841","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120048841/doc4.xml","form_type":"4"}},{"id":3069643,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-08-04T20:59:59.000Z","date":"2020-08-03","kind":"exercise","acquired":false,"shares":5700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests 1/48th of the shares monthly,commencing one month from the date of grant,  subject to reporting person's continued service through each vesting date."}],"balance_after":217311,"derivative":{"exercise_price":2.19,"expiration_date":"2018-12-12","underlying":"Common Stock","underlying_shares":5700},"source":{"system":"sec-edgar","filing":"0001209191-20-044723","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120044723/doc4.xml","form_type":"4"}},{"id":3069642,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2020-08-04T20:59:59.000Z","date":"2020-08-03","kind":"sale","acquired":false,"shares":5700,"price":24.7269,"value":140943.33,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $24.35 to $25.03 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-044723","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120044723/doc4.xml","form_type":"4"}},{"id":3069641,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":89186,"kind":"person","name":"Nash Huw M.","position":1,"cik":"0001780085","reported_name":"Nash Huw M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2020-08-04T20:59:59.000Z","date":"2020-08-03","kind":"exercise","acquired":true,"shares":5700,"price":2.19,"value":12483.0,"ownership":{"direct":true},"balance_after":5700,"source":{"system":"sec-edgar","filing":"0001209191-20-044723","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120044723/doc4.xml","form_type":"4"}}],"next_cursor":"2020-08-04T20:59:59.000000Z,3069641"}